Benoit D.
- Country
- France
- Department
- Oncology for pediatrics
Research Overview
- Evaluation of Intra-Arterial Chemotherapy with Topotecan and Drug Combination for Conservative Management of Retinoblastoma in Eligible Patients
- MetroWILMS-1906: Phase 1-2 trial evaluating metronomic chemotherapy in patients with relapsed or refractory Wilms tumor
- Phase 3 Non-Inferiority Trial of Vincristine, Actinomycin-D, and Doxorubicin Versus Vincristine, Carboplatin, and Etoposide in Stage IV Pediatric Renal Tumors
Data & Insights
Has run more than one trial at 99 of 204 partner sites.
Specializations
Ocular Oncology
This investigator specializes in the treatment of retinoblastoma, conducting research into both conservative and surgical management approaches. Their work encompasses ophthalmologic therapeutic strategies and evaluation of visual function outcomes.
- Conservative treatment methods
- Intra-arterial chemotherapy applications
- Visual outcome assessment
The research extends to investigating adjuvant treatments for extensive unilateral cases requiring primary enucleation.
Pediatric Oncology
The investigator focuses on advanced treatment strategies for high-risk neuroblastoma and other challenging pediatric cancers. Their expertise includes chemoimmunotherapy and complex treatment protocols.
- Neuroblastoma management
- Refractory solid tumors
- Innovative combination therapies
Research interests include treatment of relapsed conditions and novel therapeutic combinations for pediatric solid tumors.
Renal Oncology
The investigator conducts research in childhood renal tumors, with particular emphasis on Wilms tumor treatment. Their work includes evaluation of metronomic chemotherapy approaches and management of metastatic disease.
- Metastatic disease response
- Alternative chemotherapy protocols
- Refractory disease management
The research encompasses both initial treatment strategies and approaches for relapsed cases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.